Physician profile
Warren Groff
NPI 1558348110
$8,127.64
in general payments reported to CMS, 2019-2025
41 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,606 · 2020: $1,559 · 2021: $1,809 · 2022: $1,129 · 2023: $1,767 · 2024: $74.51 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,024.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,402.42 | 2019-2023 | Breztri, Farxiga |
| Pfizer INC. | $1,101.04 | 2019-2023 | |
| Lilly USA, LLC | $680.41 | 2019-2023 | Mounjaro, Jardiance |
| Edwards Lifesciences Corporation | $661.92 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Novo Nordisk INC | $583.59 | 2019-2023 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $314.08 | 2019-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Amarin Pharma, INC. | $296.41 | 2019-2021 | |
| Abbott Laboratories | $264.41 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $263.79 | 2019-2023 | Verquvo, Belsomra |
| Bayer Healthcare Pharmaceuticals INC. | $251.62 | 2021-2023 | |
| Eisai INC. | $240.23 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.31 | 2019-2023 | Jardiance, Ofev |
| Abbvie INC. | $205.64 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $186.69 | 2019-2022 | |
| Horizon Therapeutics Plc | $157.96 | 2020-2023 | Krystexxa |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Groff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.